Primary mucosal melanoma of the head and neck in Denmark, 1982–2012: Demographic and clinical aspects. A retrospective DAHANCA study

References

• Gavriel H, McArthur G, Sizeland A, Henderson M. Review: mucosal melanoma of the head and neck.. Melanoma Res 2011;21:257–66.
   PubMed Web of Science ®Google Scholar
• Marcus DM, Marcus RP, Prabhu RS, Owonikoko TK, Lawson DH, Switchenko J, et al. Rising incidence of mucosal melanoma of the head and neck in the United States. J Skin Cancer 2012;2012:231693.
   PubMedGoogle Scholar
• Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer 1998;83:1664–78.
   PubMed Web of Science ®Google Scholar
• Chiu NT, Weinstock MA. Melanoma of oronasal mucosa. Population-based analysis of occurrence and mortality. Arch. Otolaryngol. Head Neck Surg 1996;122:985–8.
   PubMedGoogle Scholar
• Jangard M, Hansson J, Ragnarsson-Olding B. Primary sinonasal malignant melanoma: a nationwide study of the Swedish population, 1960-2000. Rhinology 2013;51:22–30.
   PubMed Web of Science ®Google Scholar
• Thompson LDR, Wieneke JA, Miettinen M. Sinonasal tract and nasopharyngeal melanomas: a clinicopathologic study of 115 cases with a proposed staging system. Am J Surg Pathol 2003;27:594–611.
   PubMed Web of Science ®Google Scholar
• Prasad ML, Patel SG, Huvos AG, Shah JP, Busam KJ. Primary mucosal melanoma of the head and neck: a proposal for microstaging localized, Stage I (lymph node-negative) tumors. Cancer 2004;100:1657–64.
   PubMed Web of Science ®Google Scholar
• Ballantyne AJ. Malignant melanoma of the skin of the head and neck. An analysis of 405 cases. Am J Surg 1970;120:425–31.
   PubMed Web of Science ®Google Scholar
• Sobin LH, Compton CC. TNM seventh edition: what”s new, what”s changed: communication from the International Union Against Cancer and the American Joint Committee on Cancer. Cancer 2010;116:5336–9.
   PubMed Web of Science ®Google Scholar
• Jethanamest D, Vila PM, Sikora AG, Morris LGT. Predictors of survival in mucosal melanoma of the head and neck. Ann Surg Oncol 2011;18;2748–56.
   PubMed Web of Science ®Google Scholar
• Krengli M, Masini L, Kaanders JHAM, Maingon P, Oei SB, Zouhair A, et al. Radiotherapy in the treatment of mucosal melanoma of the upper aerodigestive tract: analysis of 74 cases. A Rare Cancer Network study. Int J Radiat Oncol Biol Phys 2006;65:751–9.
   PubMed Web of Science ®Google Scholar
• Patel SG, Prasad ML, Escrig M, Singh B, Shaha AR, Kraus DH, et al. Primary mucosal malignant melanoma of the head and neck. Head Neck 2002;24:247–57.
   PubMed Web of Science ®Google Scholar
• Pfister DGD, Ang K-KK, Brizel DMD, Burtness BB, Cmelak AJA, Colevas ADA, et al. Mucosal melanoma of the head and neck. J Natl Compr Canc Netw 2012;10:320–38.
   PubMed Web of Science ®Google Scholar
• McLean N, Tighiouart M, Muller S. Primary mucosal melanoma of the head and neck. Comparison of clinical presentation and histopathologic features of oral and sinonasal melanoma. Oral Oncol 2008;44:1039–46.
   PubMed Web of Science ®Google Scholar
• Papaspyrou G, Garbe C, Schadendorf D, Werner JA, Hauschild A, Egberts F. Mucosal melanomas of the head and neck: new aspects of the clinical outcome, molecular pathology, and treatment with c-kit inhibitors.. Melanoma Res 2011;21:475–82.
   PubMed Web of Science ®Google Scholar
• Koomen ER, de Vries E, van Kempen LC, van Akkooi ACJ, Guchelaar HJ, Louwman MWJ, et al. Epidemiology of extracutaneous melanoma in the Netherlands. Cancer Epidemiol Biomarker Prev 2010;19:1453–9.
   PubMed Web of Science ®Google Scholar
• Bachar G, Loh KS, O'sullivan B, Goldstein D, Wood S, Brown D, et al. Mucosal melanomas of the head and neck: experience of the Princess Margaret Hospital. Head Neck 2008;30:1325–31.
   PubMed Web of Science ®Google Scholar
• Mihajlovic M, Vlajkovic S, Jovanovic P, Stefanovic V. Primary mucosal melanomas: a comprehensive review. Int J Clin Exp Pathol 2012;5:739–53.
   PubMed Web of Science ®Google Scholar
• Shuman AG, Light E, Olsen SH, Pynnonen MA, Taylor JMG, Johnson TM, et al. Mucosal melanoma of the head and neck: predictors of prognosis. Arch Otolaryngol Head Neck Surg 2011;137:331–7.
   PubMedGoogle Scholar
• Mochel MC, Duncan LM, Piris A, Kraft S. Primary Mucosal Melanoma of the Sinonasal Tract: A Clinicopathologic and Immunohistochemical Study of Thirty-Two Cases. Head Neck Pathol 2014;9:236--243
   PubMedGoogle Scholar
• Saigal K, Weed DT, Reis IM, Markoe AM, Wolfson AH, Nguyen-Sperry J. Mucosal melanomas of the head and neck: The role of postoperative radiation therapy. ISRN Oncol 2012;2012:1–7.
   Google Scholar
• Benlyazid A, Thariat J, Temam S, Malard O, Florescu C, Choussy O, et al. Postoperative radiotherapy in head and neck mucosal melanoma: a GETTEC study. Arch Otolaryngol Head Neck Surg 2010;136:1219–25.
   PubMedGoogle Scholar
• Lund VJ, Chisholm EJ, Howard DJ, Wei WI. Sinonasal malignant melanoma: an analysis of 115 cases assessing outcomes of surgery, postoperative radiotherapy and endoscopic resection. Rhinology 2012;50:203–10.
   PubMed Web of Science ®Google Scholar
• Spencer KR, Mehnert JM. Mucosal melanoma: Epidemiology, biology and treatment. Cancer Treat Res 2016;167:295–320.
   PubMedGoogle Scholar
• Carvajal RD, Antonescu CR, Wolchok JD, Chapman PB, Roman R-A, Teitcher J, et al. KIT as a therapeutic target in metastatic melanoma. JAMA 2011;305:2327–34.
   PubMed Web of Science ®Google Scholar
• Guo J, Si L, Kong Y, Flaherty KT, Xu X, Zhu Y, et al. Phase II, open-label, single-arm trial of imatinib mesylate in patients with metastatic melanoma harboring c-Kit mutation or amplification. J Clin Oncol 2011;29:2904–9.
   PubMed Web of Science ®Google Scholar
• Hodi FS, Corless CL, Giobbie-Hurder A, Fletcher JA, Zhu M, Marino-Enriquez A, et al. Imatinib for melanomas harboring mutationally activated or amplified KIT arising on mucosal, acral, and chronically sun-damaged skin. J Clin Oncol 2013;31:3182–90.
   PubMed Web of Science ®Google Scholar
• Chapman PB, Hauschild A, Robert C, Haanen JB, Ascierto P, Larkin J, et al. Improved survival with vemurafenib in melanoma with BRAF V600E mutation. N Engl J Med 2011;364:2507–16.
   PubMed Web of Science ®Google Scholar
• Hodi FS, O'day SJ, McDermott DF, Weber RW, Sosman JA, Haanen JB, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010;363:711–23.
   PubMed Web of Science ®Google Scholar